|
|
||||||||
Rammelkamp Center for Education and Research and Department of Physiology and Biophysics, Case Western Reserve University School of Medicine, Cleveland, Ohio 44109
| |
ABSTRACT |
|---|
|
|
|---|
The effects of
maitotoxin (MTX) on plasmalemma permeability are similar to those
caused by stimulation of P2Z/P2X7
ionotropic receptors, suggesting that
1) MTX directly activates
P2Z/P2X7 receptors or
2) MTX and
P2Z/P2X7 receptor stimulation
activate a common cytolytic pore. To distinguish between these two
possibilities, the effect of MTX was examined in
1) THP-1 monocytic cells before and
after treatment with lipopolysaccharide and interferon-
, a maneuver
known to upregulate P2Z/P2X7
receptor, 2) wild-type HEK cells and
HEK cells stably expressing the
P2Z/P2X7 receptor, and
3) BW5147.3 lymphoma cells, a cell
line that expresses functional P2Z/P2X7 channels that are poorly
linked to pore formation. In control THP-1 monocytes, addition of MTX
produced a biphasic increase in the cytosolic free
Ca2+ concentration
([Ca2+]i);
the initial increase reflects MTX-induced
Ca2+ influx, whereas the second
phase correlates in time with the appearance of large pores and the
uptake of ethidium. MTX produced comparable increases in
[Ca2+]i
and ethidium uptake in THP-1 monocytes overexpressing the
P2Z/P2X7 receptor. In both
wild-type HEK and HEK cells stably expressing the
P2Z/P2X7 receptor, MTX-induced
increases in
[Ca2+]i
and ethidium uptake were virtually identical. The response of BW5147.3
cells to concentrations of MTX that produced large increases in
[Ca2+]i
had no effect on ethidium uptake. In both THP-1 and HEK cells, MTX- and
Bz-ATP-induced pores activate with similar kinetics and exhibit similar
size exclusion. Last, MTX-induced pore formation, but not channel
activation, is greatly attenuated by reducing the temperature to
22°C, a characteristic shared by the
P2Z/P2X7-induced pore. Together,
the results demonstrate that, although MTX activates channels that are
distinct from those activated by
P2Z/P2X7 receptor stimulation, the
cytolytic/oncotic pores activated by MTX- and Bz-ATP are indistinguishable.
THP-1 monocytes; HEK cells; heterologous expression; oncosis; vital dyes
| |
INTRODUCTION |
|---|
|
|
|---|
IN THE ACCOMPANYING STUDY IN human skin fibroblasts (31), we confirmed that maitotoxin (MTX), one of the most potent marine toxins known, produces a dramatic increase in cytosolic free Ca2+ concentration ([Ca2+]i). This rise in [Ca2+]i is unrelated to mobilization of Ca2+ from internal stores but rather results from a MTX-induced activation of nonselective cation channels present in the plasmalemma. The activation of these channels by MTX is followed closely in time by the formation of large pores that allow the flux of vital dyes, such as ethidium and YO-PRO-1, into the cell and the release of cell-associated fura 2. At much later times, MTX causes the release of lactate dehydrogenase (LDH), an event that presumably signals oncotic cell death. This sequence of permeability changes is reminiscent of the changes observed in many cells following stimulation of P2Z/P2X7 receptors (10, 12, 26, 43). The P2Z/P2X7 receptor is the seventh member of the P2X receptor family (35). P2X receptors are thought to form Ca2+-permeable, nonselective cation channels activated by extracellular ATP. The P2Z/P2X7 receptor has the novel characteristic of inducing the formation of large pores, which, like MTX, allow the entry of large organic vital dyes into the cell and ultimately causes the release of LDH and cell death by oncosis.
Although it is clear that heterologous expression of the P2Z/P2X7 receptor is associated with expression of both functional channels and pores, the actual structure of the pore-forming subunit remains unknown. Likewise, the actual biophysical properties of the P2Z/P2X7 channel that allow formation of pores have not been defined. It has been suggested that individual P2Z/P2X7 subunits may aggregate to form pores of increasing size and hence allow larger and larger molecules to cross the plasmalemma (26, 36). However, there is little evidence to date that the pore is actually composed of P2Z/P2X7 protein subunits, and it remains possible that an endogenous pore structure present in the cells employed for heterologous expression is activated following stimulation of P2Z/P2X7 channels by purinergic agonists.
The finding that MTX induces formation of large pores with
characteristics similar to
P2Z/P2X7 receptor-induced pores
suggests two possibilities: 1) MTX
is a high-affinity ligand for the
P2Z/P2X7 receptor or
2) MTX and
P2Z/P2X7 receptor stimulation
activate distinct channels but a common cytolytic pore. To distinguish between these two possibilities, the effect of MTX was examined in
cells in which the expression of functional
P2Z/P2X7 channels and pores could
be varied either by alterations in the growth conditions or by
heterologous expression. In the first set of experiments, the effect of
MTX was examined in THP-1 monocytes. These cells express low levels of
P2Z/P2X7 receptor under normal growth conditions, but pretreatment of these cells with bacterial lipopolysaccharide (LPS) and interferon-
(IFN-
) dramatically upregulates P2Z/P2X7 message and
function (18). In the second set of experiments, the effect of MTX was
examined in control HEK cells and in HEK cells stably expressing the
P2Z/P2X7 receptor. Last, the
effect of MTX on BW5147.3 cells, a cell line that expresses P2Z/P2X7 receptors that are poorly
coupled to pore formation (20), was examined. The results suggest that
MTX activates channels that are distinct from those activated by
stimulation of P2Z/P2X7 receptors;
however, the characteristics of the MTX-induced pores are
indistinguishable from the pores activated by
P2Z/P2X7 receptor stimulation. A
physical model is proposed in which MTX-activated channels and
P2Z/P2X7 receptor-activated
channels compete for a common cytolytic pore.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Solutions and reagents.
Unless otherwise indicated, HEPES-buffered saline (HBS) contained 140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 10 mM D-glucose, 1.8 mM
CaCl2, 15 mM HEPES, and 0.1% BSA,
pH adjusted to 7.40 at 37°C with NaOH.
Ca2+-free HBS contained 0.3 mM
EGTA and the same salts as HBS without added
CaCl2. Fura 2-AM, ethidium
bromide, YO-PRO-1, and POPO-3 were obtained from Molecular Probes
(Eugene, OR). MTX was obtained from Calbiochem (San Diego, CA) or from
LC Laboratories (Woburn, MA) and was stored in amber-colored glass or
plastic vials at
20°C as an aqueous stock solution (>1
µM) with 0.1% BSA. 2' and 3'-O-(4-benzoylbenzoyl)-ATP
(Bz-ATP) was obtained from Sigma Chemical (St. Louis, MO). All other
salts and chemicals were of reagent grade.
Cell culture.
The THP-1 monocytic cell line was obtained from American Type Culture
Collection (ATCC) and grown in RPMI 1640 containing 10%
heat-inactivated fetal bovine serum (FBS), 1%
penicillin-streptomycin-neomycin (PSN) antibiotic mixture,
and 2 mM L-glutamine in spinner
flasks as previously described (18). In some experiments, the
P2Z/P2X7 receptor was upregulated
by pretreatment of THP-1 cells for 48 h in complete RPMI 1640 medium
containing 1 µg/ml bacterial LPS and 1,000 U/ml IFN-
. Wild-type
HEK cells were obtained from ATCC and grown in MEM supplemented with
10% FBS, 1% PSN antibiotic mixture, and 2 mM
L-glutamine. For passage, cells
were dispersed by trypsin treatment and seeded at a density of ~3 × 103
cells/cm3. The medium was changed
every 2-3 days after seeding. HEK cells were harvested for
experimentation when the cells had reached confluence. HEK cells stably
expressing the human P2Z/P2X7
receptor were generated as previously described (19) and cultured in a
fashion identical to wild-type HEK. BW5147.3, a murine lymphoma cell
line, was obtained from ATCC and grown in spinner flasks in
DMEM supplemented with 10% FBS, 1% PSN antibiotic
mixture, and 2 mM L-glutamine.
Uptake of vital dyes. The uptake of ethidium, YO-PRO-1, and POPO-3 was determined in the absence and presence of MTX or Bz-ATP as previously described (31).
Measurement of the apparent [Ca2+]i. [Ca2+]i was measured using the fluorescent indicator fura 2 as previously described (30, 31). Unless otherwise indicated, all measurements were performed at 37°C. Calibration of the fura 2 associated with the cells was accomplished using Triton X-100 lysis in the presence of saturating divalent cation concentrations followed by addition of EGTA (pH 8.5). [Ca2+]i was calculated by the equation of Grynkiewicz et al. (15) using a dissociation constant value for Ca2+ binding to fura 2 of 224 nM. As reported in the accompanying paper (31), MTX causes fura 2 efflux from cells. Therefore, where indicated, [Ca2+]i values are reported as "apparent" changes in [Ca2+]i.
Data presentation and statistical treatment. Figures 1-12 show representative traces from experiments performed at least three times. For mean values, traces recorded under identical conditions on one day were pooled yielding an n of 1. Where indicated, n equals the number of independent experiments and statistical differences between means were determined by Student's t-test, with P < 0.05 considered significant. To control for cell-to-cell and day-to-day variation, all traces shown within each panel of Figs. 1-12 were obtained on the same day and on the same batch of cells. Where indicated, traces in multiple panels of a figure were also paired. For example, the traces shown in both A and B of Fig. 3 were obtained on the same day on the same batch of THP-1 cells, divided into control and treated groups.
| |
RESULTS |
|---|
|
|
|---|
Effect of MTX on THP-1 monocytes.
The results of our accompanying study (31) on fibroblasts suggested two
possibilities: 1) MTX activates
P2Z/P2X7 or
2) MTX and the
P2Z/P2X7 receptor activate
distinct channels but a common cytolytic pore. If MTX activates the
P2Z/P2X7 receptor, then the response to MTX should be proportional to the level of expression of
the P2Z/P2X7 receptor. Previous
studies have shown that P2Z/P2X7 expression is low in control THP-1 monocytes but can be dramatically upregulated by pretreatment of the cells with LPS and IFN-
for 24-48 h (18). The effect of MTX on
[Ca2+]i
in control THP-1 cells is shown in Fig. 1.
MTX produced a concentration-dependent, biphasic change in
[Ca2+]i.
At the lowest concentration tested (2 pM), MTX initially produced a
significant 1.8-fold increase in
[Ca2+]i
from a resting level of 71.8 ± 6.7 nM to a sustained level of 129.6 ± 20 nM (means ± SE, n = 7, P < 0.01). After a delay of ~5 min,
[Ca2+]i
began to increase again with time. Increasing the concentration of MTX
produced a decrease in the delay time between the first and second
phase with little change in the subsequent rate of increase of
[Ca2+]i
(Fig. 1A). Thus the first phase
appears to be concentration dependent, whereas the second phase appears
to be all or nothing. As the concentration of MTX increased from 25 pM
to 2 nM, the first and second phase gradually merged into a single
response (Fig. 1B). Addition of MTX
in the absence of extracellular
Ca2+ had no effect, but a large
increase in
[Ca2+]i
was observed on subsequent addition of the
Ca2+ to the bath solution (data
not shown). Thus, as previously shown, MTX does not release
Ca2+ from internal stores but
initially stimulates Ca2+ influx
from the extracellular space. Note that there is a "crossover" phenomenon seen in this experiment at the three highest concentrations of MTX tested. This was a consistent finding (see Figs.
3A and 8A); the maximum level of apparent
[Ca2+]i
was generally greater for the lower concentrations vs. the higher
concentrations of MTX, at least over this time frame.
|
|
Effect of P2Z/P2X7 receptor upregulation
on the response to MTX.
THP-1 monocytes were incubated with LPS and IFN-
for 48 h to
upregulate P2Z/P2X7 as previously
described (18). Increased expression of
P2Z/P2X7 was confirmed in the
present study by primer-specific amplification using RT-PCR (data not
shown). Compared with matched controls, LPS and IFN-
pretreatment
increased basal resting
[Ca2+]i
from 65.2 ± 12 to 115 ± 27 nM (means ± SE,
n = 3, P = 0.085) and produced an attenuation
the response of the cells to MTX (Fig. 3).
The primary effect of LPS and IFN-
pretreatment was on the second
phase of the response to MTX (e.g., compare the
[Ca2+]i
response to 20 pM MTX in control and LPS- and IFN-
-treated cells;
Fig. 3, trace c in
A and
B). This result suggests that upregulation of P2Z/P2X7 may
reduce MTX-induced pore formation. Consistent with this hypothesis, LPS
and IFN-
pretreatment slightly inhibited MTX-induced ethidium uptake
at concentrations <0.5 nM (Fig. 4). At
0.5 nM MTX, ethidium uptake in LPS- and IFN-
-treated cells was
actually greater than in controls and the crossover phenomenon was not
observed over this concentration range. This suggests that the
crossover may be related to
[Ca2+]i,
which is clearly attenuated in the cells expressing the
P2Z/P2X7 receptor. Importantly,
control THP-1 cells, which essentially lack the
P2Z/P2X7 receptor, and pretreated
cells, which have a high level of receptor expression, both respond to
MTX. This result supports the hypothesis that the channels activated by
MTX are distinct from P2Z/P2X7.
|
|
Effect of MTX on heterologously expressed
P2Z/P2X7 receptor.
To further test the hypothesis that MTX activates the
P2Z/P2X7 receptor, the effect of
MTX on
[Ca2+]i
and ethidium uptake was examined in wild-type HEK cells and in HEK
cells stably expressing the
P2Z/P2X7 receptor. Basal,
nonstimulated [Ca2+]i
was 56.4 ± 6.9 and 50.2 ± 3.8 nM (means ± SE;
n = 3) in wild-type HEK
and P2Z/P2X7-expressing cells
(Fig. 5). The wild-type HEK cells were
essentially unresponsive to Bz-ATP (up to 200 µM), a specific
P2Z/P2X7 receptor agonist. In
sharp contrast, addition of Bz-ATP to HEK cells expressing the
P2Z/P2X7 receptor produced a
concentration-dependent increase in both
[Ca2+]i
(Fig. 5A) and ethidium uptake (Fig.
5B), consistent with both channel
and pore formation. The responses of these two cell types to MTX are
shown in Figs. 6 and
7. MTX produced a time- and
concentration-dependent increase in both apparent
[Ca2+]i
and ethidium uptake. The response was virtually identical for wild-type
HEK cells and the
P2Z/P2X7-expressing cells.
Together with the results obtained in the THP-1 monocytes, these
results strongly suggest that expression of the
P2Z/P2X7 receptor has little
effect on MTX-induced channel activation, a result that is inconsistent
with MTX acting as a high-affinity ligand for the
P2Z/P2X7 receptor.
|
|
|
Effect of temperature on MTX-induced pore formation.
The above results provide evidence that MTX activates a
Ca2+-permeable channel that is
distinct from the P2Z/P2X7
receptor channels. However, the experiments do not eliminate the
possibility that activation of the MTX-sensitive channel and the
P2Z/P2X7 channel induce the
formation of a common cytolytic pore. To test this hypothesis, we have
compared the properties of the
P2Z/P2X7-induced pores to those
activated by MTX. Previous studies have shown that a decrease in
temperature has little effect on
P2Z/P2X7-induced channel activity
(i.e., the change in
[Ca2+]i)
but substantially attenuates pore formation (i.e., dye uptake) (26,
33). To determine if the MTX-induced pores have the same characteristic, we compared the MTX response of the control THP-1 monocytes at 37 and 22°C (Figs. 8 and
9). Although there is a shift in the
apparent ED50 for MTX-induced
change in
[Ca2+]i,
large increases in
[Ca2+]i
were clearly observed at 0.2 and 0.5 nM MTX at 22°C (Fig.
8B). The response, however, lacked
the biphasic characteristic seen at 37°C, suggesting that the
second phase of the response was attenuated. Consistent with this
hypothesis, ethidium uptake was dramatically inhibited at all
concentrations of MTX when examined at 22°C (Fig. 9). Thus
MTX-induced pore formation has a temperature sensitivity similar to
that previously reported for the
P2Z/P2X7 pore.
|
|
Effect of MTX on
[Ca2+]i
and ethidium uptake in BW5147.3 lymphoma cells.
Previous studies suggest that BW5147.3 lymphoma cells express
functional P2Z/P2X7 channels that
are poorly coupled to pore formation (20). The effect of MTX in this
cell line is shown in Fig. 10. Basal,
nonstimulated
[Ca2+]i
in BW5147.3 cells was 197 ± 16 nM (means ± SE;
n = 4), a value that is approximately
threefold greater than that measured in either control THP-1 monocytes
(P < 0.002) or in wild-type HEK cells (P < 0.001). MTX (0.05 and 0.2 nM) produced a large, concentration-dependent increase in
[Ca2+]i
in BW5147.3 lymphoma cells that increased gradually with time over 6 min. In contrast, uptake of ethidium was unaffected by MTX at these
concentrations, even when examined for extended periods of time (13 min; see Fig. 10, inset). Ethidium
uptake was, however, observed in BW5147.3 cells in response to
supermaximal concentrations (2-20 nM) of MTX (not shown). Thus
BW5147.3 cells apparently have MTX-activated channels that are poorly
coupled to pore formation, as previously noted for the
P2Z/P2X7 response in this cell
line.
|
Comparison of MTX- and Bz-ATP-induced pore size.
Another characteristic of the
P2Z/P2X7-induced pore is that the
apparent size exclusion varies with cell type (10). We, therefore,
compared MTX- and Bz-ATP-induced ethidium (314 Da), YO-PRO (375 Da),
and POPO-3 (715 Da) uptake in HEK cells and THP-1 monocytes expressing
the P2Z/P2X7 receptor. In HEK
cells, both Bz-ATP (200 µM) and MTX (1 nM) produced a time-dependent
increase in ethidium uptake (Fig. 11);
however, uptake of YO-PRO was much slower, and uptake of POPO-3 was
essentially zero over this time frame. Thus MTX- and Bz-ATP-induced
pores activate with a similar time course and have the same relative
permeability in HEK cells, i.e., ethidium > YO-PRO
POPO-3. In
sharp contrast to the HEK cells, MTX (50 pM) and Bz-ATP (200 µM)
increased the uptake of all three dyes into THP-1 monocytes (Fig.
12). Thus the pores formed in THP-1
monocytes appear to be larger than those seen in HEK cells and, as
suggested above, seem to activate in an all-or-nothing fashion. One
note of caution, release of LDH in response to Bz-ATP occurs very soon
after ethidium uptake in THP-1 cells pretreated with LPS and IFN-
(18). This could explain, in part, the differences between HEK and
THP-1 cells with respect to apparent size exclusion. Importantly,
however, the profiles of permeability change induced by MTX and Bz-ATP
are essentially identical in the two cell types with respect to
kinetics of activation and apparent size exclusion.
|
|
| |
DISCUSSION |
|---|
|
|
|---|
MTX is one of the most potent marine toxins isolated to date. This toxin produces increases in [Ca2+]i in all cell tested via the activation of Ca2+-permeable, nonselective cation channels. The results of the present study demonstrate that THP-1 monocytes are extremely sensitive to MTX with apparent ED50 of ~10 pM, estimated from the initial change in [Ca2+]i. In our accompanying study using human skin fibroblasts (31), we showed for the first time that MTX also activates large pores that allow molecules with molecular masses up to 800 Da to enter or exit the cell. In fibroblasts, this pore formation occurred with a short delay following channel activation, and a similar result was obtained in the present study in HEK cells. However, in THP-1 monocytes, a considerable lag was observed between the initial activation of the channel and subsequent pore formation. Once pore formation was initiated in the THP-1 monocytes, it occurred in an all-or-nothing fashion, causing large increases in ethidium, YO-PRO-1, and POPO-3 uptake into the cells. The lag phase would suggest that there may be several biochemical steps between channel activation and pore formation or that the concentration of a critical messenger or factor may need to exceed a threshold value before activation of the pore is observed. An enzymatic step(s) between channel activation and pore formation is also supported by the sensitivity of pore formation to temperature. As shown in our previous studies on fibroblasts, reducing the temperature substantially increased the lag time between channel activation and pore formation, and the results of the present study on THP-1 monocytes clearly shows that, at concentrations of MTX that substantially increase [Ca2+]i, pore formation is essentially reduced to zero at 22°C. The biochemical events responsible for coupling of channel activation to pore formation remain unknown. In this regard, the crossover phenomenon seen in the THP-1 monocytes may provide a clue. At low concentrations of MTX, pore formation appears to occur in an all-or-nothing fashion after a considerable lag time. However, at the higher concentrations of MTX associated with the crossover phenomenon, (i.e., inhibition of pore formation), a rapid increase in [Ca2+]i was observed. Thus an increase in [Ca2+]i may produce feedback inhibition. Interestingly, the resting [Ca2+]i in the BW5147.3 lymphoma cells is approximately threefold higher than in THP-1 cells and pore formation induced by either Bz-ATP or MTX is substantially attenuated, supporting this hypothesis. Understanding this regulation will require greater knowledge of the molecular/biochemical link between channel activation and pore formation.
The only documented example of channels linked to activation of large
pores are members of the P2X ionotropic receptor family (21, 40), of
which P2Z/P2X7 is the best-studied
example. The P2Z/P2X7 receptor is
a protein of 595 amino acids in length possessing two putative
transmembrane segments with cytoplasmic
NH2- and COOH-terminal domains
(35). It has a structure similar to the inwardly rectifying
K+ channels, amiloride-sensitive
Na+ channels and the
mechanosensitive Mec channels of Caenorhabditis elegans (2). Each of these channel families has a
cytoplasmic NH2 and COOH terminus,
two membrane spanning segments, and a permeation pathway formed by a
reentrance loop immediately preceding the second
transmembrane segment. These channels are thought to form homo- and
heteromeric channel structures. On the basis of structural similarity,
the P2X purinergic receptor family may form channels in a similar
fashion, i.e., by homo- or heteromeric assembly (39), and it has been
suggested that P2Z/P2X7-induced
pore formation reflects the progressive association/aggregation of
channel-forming subunits into a large pore structure (26, 36), although
evidence to support such a biophysical model is scant. It became clear early in the present study that MTX-induced pores share many
characteristics with the pores formed following activation of
P2Z/P2X7 receptors/channels. Therefore, we initially focused on the intriguing possibility that MTX
was a high-affinity ligand for
P2Z/P2X7. The results of the
present study however, demonstrate that this is not the case.
First, untreated THP-1 cells and wild-type HEK-293 cells show little response to Bz-ATP, suggesting that functional
P2Z/P2X7 receptors are not
expressed or are expressed at very low levels, yet both cell types are
sensitive to MTX, exhibiting both large increases in
[Ca2+]i
and fluorescent dye uptake. Thus the MTX-activated channel and pore are
functional in the apparent absence of
P2Z/P2X7 receptor. Second,
upregulation of the P2Z/P2X7 in
THP-1 cells by pretreatment with LPS and IFN-
greatly enhances both
the rise in
[Ca2+]i
and the uptake of fluorescent dyes in response to Bz-ATP (18) but
slightly attenuates the response of the cells to MTX. Third, heterologous expression of
P2Z/P2X7 in HEK-293 cells
dramatically increases the response of the cells to Bz-ATP but has
little or no effect on the response to MTX. Together, these results
demonstrate that expression of
P2Z/P2X7 does not correlate with
MTX responsiveness, and provide strong support for the conclusion that
P2Z/P2X7 is not the MTX-activated channel.
Although the channels appear to be different, the MTX- and Bz-ATP-induced pores are indistinguishable, leading to the hypothesis that MTX and P2Z/P2X7 activate a common cytolytic pore. This conclusion is based on the following results. First, all cells examined in the present study that exhibit Bz-ATP-induced pores also possess the MTX-induced pore. Second, the pores for both agonists activate with a similar time course following stimulation of the channel activity and this time course of activation is cell specific. Thus, as discussed above, MTX- and Bz-ATP-induced channel activation is followed closely in time by the formation of pores in HEK cells, but this activation requires a considerable lag time in THP-1 cells. Third, the MTX and Bz-ATP-induced pores have similar size exclusions. In HEK, there is a clear difference in ethidium, YO-PRO-1, and POPO-3 uptake for both MTX and Bz-ATP, whereas, in THP-1 cells, uptake of each dye is observed for both agonists. Fourth, BW5147.3 lymphoma cells appear to have Bz-ATP- (20) and MTX-induced channels that are poorly coupled to pore formation. Finally, fifth, both MTX- and Bz-ATP-induced pores have similar temperature sensitivity. Overall, we could find no characteristic that would distinguish between these two pores. Although we cannot eliminate the possibility that each agonist activates different channels and different pores, it is difficult to reconcile the similarities with such a model; even cell-specific characteristics such as kinetics of activation, size exclusion, and the inefficient coupling between channel and pore seen in BW5147.3 cells are essentially identical for MTX- and Bz-ATP-induced pores. Thus the simplest explanation for these results is that MTX and Bz-ATP activate distinct channels but a common cytolytic pore.
Evidence in the literature demonstrating identity between P2Z/P2X7 channels and pores is very limited and relies on heterologous expression. These reports show that P2X receptor expression is required for responsiveness to externally applied purinergic receptors agonists and that channels formed by different P2X subunits, either alone or in various combinations, possess unique biophysical properties (13, 14, 21, 24, 26, 28, 34, 39, 40). Thus it is likely that the P2X protein forms at least part of both the agonist binding domain and the channel permeation pathway. The results of the present study support this hypothesis. However, it remains possible that heterologously expressed P2Z/P2X7 protein does not form the pore but rather is coupling (either physically or biochemically) to endogenous pores in the cell types used for expression. The most common cell types used for heterologous expression of P2Z/P2X7 receptors are the HEK cell and frog oocyte. In this regard, it is clear from the present study that HEK cells have an endogenous pore that is activated by MTX. Furthermore, it has recently been shown (1) that frog oocytes have an MTX-induced nonselective cation current that initially excludes the large cation N-methyl-D-glucamine (NMDG) (167 Da). Although these authors did not specifically test for pore formation, it is clear from their current recordings that a conductance to NMDG developed at later times following MTX addition to the external bath, consistent with pore formation. Furthermore, all cells examined to date respond to MTX with large increases in [Ca2+]i and/or downstream Ca2+-dependent signaling events (1, 6, 8, 9, 16, 17, 22, 25, 29). Thus it seems likely that most, if not all cells, have an endogenous MTX-activated cytolytic pore, including cell types used for heterologous expression of P2Z/P2X7 receptors.
The model shown in Fig. 13 proposes that
the P2X purinergic ionotropic receptors and the channels activated by
MTX interact with a common cytolytic/oncotic pore, or COP. Although the
model suggests that the coupling between channel and COP is membrane delimited, cytosolic proteins or factors may play a role in activation of COP. As was seen in Fig. 4, however, overexpression of
P2Z/P2X7 in THP-1 cells causes an
attenuation of MTX-induced pore formation, which could be overcome by
increasing the concentration of MTX. Thus it appears that
P2Z/P2X7 may compete with the
MTX-induced channel for activation of COP, suggesting a preexisting
channel-pore complex. In this regard, attenuation of the MTX response
by expression of P2Z/P2X7 in THP-1
cells may reflect a greater affinity of
P2Z/P2X7 for COP relative to the
MTX channel or alternatively may reflect the amount and/or
number of P2Z/P2X7
receptors relative to MTX channels in these cells. Irrespective of the
exact mechanism of coupling between channel and COP, MTX should provide
a useful tool for understanding this interaction.
|
Although the experiments of the present study focused on P2Z/P2X7-mediated and MTX-induced COP activation, two recent studies demonstrate that other members of the P2X family can, to various extents, initiate pore formation and that mutations at specific residues within the second membrane spanning segment can differentially alter transition from channel to pore (21, 40). These experiments were performed in both frog oocytes and HEK cells heterologously expressing the various P2X receptor subtypes and mutants. Thus, although these investigators interpreted their results as reflecting a conformational change or dilation of the P2X permeation pathway, the findings are not inconsistent with differential activation of the endogenous COP in these cell types. Furthermore, P2X- and MTX-activated channels may not be the only channels linked to COP. Indeed, activation of a number of different channel types has been shown to produce oncotic cell death. These include the VR1 vanilloid receptor, which is responsible for pain sensation associated with stimulation by capsaicin, the active compound in chili peppers (3), the NR1-NR2 N-methyl-D-aspartate glutamate receptor, which has been implicated in excitatory neurotoxicity (5, 7, 37, 38), and the degenerins family of ion channels, responsible for hereditary neurodegeneration in C. elegans (4). Interestingly, heterologous expression in HEK cells of the mammalian degenerin MDEG, with the same mutation as that found in C. elegans neurodegeneration phenotypes, gives rise to constitutively active channels that cause cell death by swelling (41). Thus it is possible that the activity of a number of different channels may be coupled to oncosis by activation of COP.
Last, activation of COP need not always proceed to cell death by oncosis. Substantial evidence supports the hypothesis that apoptosis and oncosis reflect different endpoints of a common cell death pathway (11, 23, 27, 37). In this regard, activation of COP by extracellular ATP is associated with both apoptosis and oncosis in mesangial cells (32) and thymocytes (44). Furthermore, Warny and Kelly (42) recently showed that oncosis in THP-1 monocytes is mediated by loss of cellular K+ and activation of caspase-like proteases (42), a hallmark of apoptotic cell death. Under normal ionic conditions, it seems likely that activation of COP will lead to pronounced loss of cellular K+ in exchange for extracellular Na+ and Ca2+, which may lead to either apoptosis or oncosis, depending possibly on the metabolic status of the cell. In any event, it will be important to define the role of COP in both types of cell death and to identify and characterize the COP protein at the molecular level.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Drs. Diana L. Kunze and Mark Estacion for helpful discussions and acknowledge the technical assistance of Erin McGowan.
| |
FOOTNOTES |
|---|
This work was supported by National Institute of General Medical Sciences Grants GM-52019 (W. P. Schilling) and GM-36387 (G. R. Dubyak) and by a Postdoctoral Fellowship awarded to W. G. Sinkins by the American Heart Association, Northeast Ohio Affiliate.
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: W. P. Schilling, Rammelkamp Center for Education and Research, MetroHealth Medical Center, Rm. R322, 2500 MetroHealth Dr., Cleveland, OH 44109-1998 (E-mail: wschilling{at}metrohealth.org).
Received 11 May 1999; accepted in final form 24 June 1999.
| |
REFERENCES |
|---|
|
|
|---|
1.
Bielfeld-Ackermann, A.,
C. Range,
and
C. Korbmacher.
Maitotoxin (MTX) activates a non-selective cation channel in Xenopus laevis oocytes.
Pflügers Arch.
436:
329-337,
1998[Medline].
2.
Brake, A. J.,
M. J. Wagenbach,
and
D. Julius.
New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor.
Nature
371:
519-523,
1994[Medline].
3.
Caterina, M. J.,
M. A. Schumacher,
M. Tominaga,
T. A. Rosen,
J. D. Levine,
and
D. Julius.
The capsaicin receptor: a heat-activated ion channel in the pain pathway.
Nature
389:
816-824,
1997[Medline].
4.
Chalfie, M.,
and
E. Wolinsky.
The identification and suppression of inherited neurodegeneration in Caenorhabditis elegans.
Nature
345:
410-416,
1990[Medline].
5.
Choi, D. W.
Ionic dependence of glutamate neurotoxicity.
J. Neurosci.
7:
369-379,
1987[Abstract].
6.
Columbo, M.,
M. Taglialatela,
J. A. Warner,
D. W. MacGlashan, Jr.,
T. Yasumoto,
L. Annunziato,
and
G. Marone.
Maitotoxin, a novel activator of mediator release from human basophils, induces large increases in cytosolic calcium resulting in histamine, but not leukotriene C4, release.
J. Pharmacol. Exp. Ther.
263:
979-986,
1992
7.
Coyle, J. T.,
and
P. Puttfarcken.
Oxidative stress, glutamate, and neurodegenerative disorders.
Science
262:
689-695,
1993
8.
Daly, J. W.,
J. Lueders,
W. L. Padgett,
Y. Shin,
and
F. Gusovsky.
Maitotoxin-elicited calcium influx in cultured cells effect: effect of calcium-channel blockers.
Biochem. Pharmacol.
50:
1187-1197,
1995[Medline].
9.
Dietl, P.,
and
H. Völkl.
Maitotoxin activates a nonselective cation channel and stimulates Ca2+ entry in MDCK renal epithelial cells.
Mol. Pharmacol.
45:
300-305,
1994[Abstract].
10.
Dubyak, G. R.,
and
C. El-Moatassim.
Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides.
Am. J. Physiol.
265 (Cell Physiol. 34):
C577-C606,
1993
11.
Eguchi, Y.,
S. Shimizu,
and
Y. Tsujimoto.
Intracellular ATP levels determine cell death fate by apoptosis or necrosis.
Cancer Res.
57:
1835-1840,
1997
12.
Falzoni, S.,
M. Munerati,
D. Ferrari,
S. Spisani,
S. Moretti,
and
F. DiVirgilio.
The purinergic P2Z receptor of human macrophage cells: characterization and possible physiological role.
J. Clin. Invest.
95:
1207-1216,
1995.
13.
Garcia-Guzman, M.,
F. Soto,
J. M. Gomez-Hernandez,
P. E. Lund,
and
W. Stühmer.
Characterization of recombinant human P2X4 receptor reveals pharmacological differences to the rat homologue.
Mol. Pharmacol.
51:
109-118,
1997
14.
Garcia-Guzman, M.,
W. Stühmer,
and
F. Soto.
Molecular characterization and pharmacological properties of the human P2X3 purinoceptor.
Mol. Brain Res.
47:
59-66,
1997[Medline].
15.
Grynkiewicz, G.,
M. Poenie,
and
R. Y. Tsien.
A new generation of Ca2+ indicators with improved fluorescence properties.
J. Biol. Chem.
260:
3440-3450,
1985
16.
Gusovsky, F.,
and
J. W. Daly.
Maitotoxin: a unique pharmacological tool for research on calcium-dependent mechanisms.
Biochem. Pharmacol.
39:
1633-1639,
1990[Medline].
17.
Gutierrez, D.,
L. D. De León,
and
L. Vaca.
Characterization of the maitotoxin-induced calcium influx pathway from human skin fibroblasts.
Cell Calcium
22:
31-38,
1997[Medline].
18.
Humphreys, B. D.,
and
G. R. Dubyak.
Induction of the P2z/P2X7 nucleotide receptor and associated phospholipase D activity by lipopolysaccharide and IFN-
in the human THP-1 monocytic cell line.
J. Immunol.
157:
5627-5637,
1996[Abstract].
19.
Humphreys, B. D.,
and
G. R. Dubyak.
Modulation of P2X7 nucleotide receptor expression by pro- and anti-inflammatory stimuli in THP-1 monocytes.
J. Leukoc. Biol.
64:
265-273,
1998[Abstract].
20.
Humphreys, B. D.,
C. Virginio,
A. Surprenant,
J. Rice,
and
G. R. Dubyak.
Isoquinolines as antagonists of the P2X7 nucleotide receptor: high selectivity for the human versus rat receptor homologues.
Mol. Pharmacol.
54:
22-32,
1998
21.
Khakh, B. S.,
X. R. Bao,
C. Labarca,
and
H. A. Lester.
Neuronal P2X transmitter-gated cation channels change their ion selectivity in seconds.
Nat. New Biol.
2:
322-330,
1999.
22.
Kutty, R. K.,
Y. Singh,
G. Santostasi,
and
G. Krishna.
Maitotoxin-induced liver cell death involving loss of cell ATP following influx of calcium.
Toxicol. Appl. Pharmacol.
101:
1-10,
1989[Medline].
23.
Leist, M.,
and
P. Nicotera.
The shape of cell death.
Biochem. Biophys. Res. Commun.
236:
1-9,
1997[Medline].
24.
Lewis, C.,
S. Neidhart,
C. Holy,
R. A. North,
G. Buell,
and
A. Surprenant.
Coexpression of P2x2 and P2x3 receptor subunits can account for ATP-gated currents in sensory neurons.
Nature
377:
432-435,
1995[Medline].
25.
Murata, M.,
F. Gusovsky,
and
J. W. Daly.
Selective stimulation of Ca2+ flux in cells by maitotoxin.
Eur. J. Pharmacol.
227:
43-49,
1992[Medline].
26.
Nuttle, L. C.,
and
G. R. Dubyak.
Differential activation of cation channels and non-selective pores by macrophage P2z purinergic receptors expressed in Xenopus oocytes.
J. Biol. Chem.
269:
13988-13996,
1994
27.
Pang, Z.,
and
J. W. Geddes.
Mechanisms of cell death induced by the mitochondrial toxin 3-nitropropionic acid: acute excitotoxic necrosis and delayed apoptosis.
J. Neurosci.
17:
3064-3073,
1997
28.
Rassendren, F.,
G. N. Buell,
C. Virginio,
G. Collo,
R. A. North,
and
A. Surprenant.
The permeabilizing ATP receptor, P2X7: cloning and expression of a human cDNA.
J. Biol. Chem.
272:
5482-5486,
1997
29.
Santostasi, G.,
R. K. Kutty,
A. L. Bartorelli,
T. Yasumoto,
and
G. Krishna.
Maitotoxin-induced myocardial cell injury: calcium accumulation followed by ATP depletion preceded cell death.
Toxicol. Appl. Pharmacol.
102:
164-173,
1990[Medline].
30.
Schilling, W. P.,
L. Rajan,
and
E. Strobl-Jager.
Characterization of the bradykinin-stimulated calcium influx pathway of cultured vascular endothelial cells: saturability, selectivity and kinetics.
J. Biol. Chem.
264:
12838-12848,
1989
31.
Schilling, W. P.,
W. G. Sinkins,
and
M. Estacion.
Maitotoxin activates a nonselective cation channel and a P2Z/P2X7-like cytolytic pore in human skin fibroblasts.
Am. J. Physiol.
277 (Cell Physiol. 46):
C755-C765,
1999
32.
Schulze-Lohoff, E.,
C. Hugo,
S. Rost,
S. Arnold,
A. Gruber,
B. Brune,
and
R. B. Sterzel.
Extracellular ATP causes apoptosis and necrosis of cultured mesangial cells via P2Z/P2X7 receptors.
Am. J. Physiol.
275 (Renal Physiol. 44):
F962-F971,
1998
33.
Steinberg, T. H.,
A. S. Newman,
J. A. Swanson,
and
S. C. Silverstein.
ATP4
permeabilizes the plasma membrane of mouse macrophages to fluorescent dyes.
J. Biol. Chem.
262:
8884-8888,
1987
34.
Stoop, R.,
A. Surprenant,
and
R. A. North.
Different sensitivities to pH of ATP-induced currents at four cloned P2X receptors.
J. Neurophysiol.
78:
1837-1840,
1997
35.
Surprenant, A.,
F. Rassendren,
E. Kawashima,
R. A. North,
and
G. Buell.
The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7).
Science
272:
735-738,
1996[Abstract].
36.
Tatham, P. E. R.,
and
M. Lindau.
ATP-induced pore formation in the plasma-membrane of rat peritoneal mast cells.
J. Gen. Physiol.
95:
459-476,
1990
37.
Toescu, E. C.
Apoptosis and cell death in neuronal cells: where does Ca2+ fit in?
Cell Calcium
24:
387-403,
1998[Medline].
38.
Tokita, Y.,
Y. Bessho,
M. Masu,
K. Nakamura,
K. Nakao,
M. Katsuki,
and
S. Nakanishi.
Characterization of excitatory amino acid neurotoxicity in N-methyl-D-aspartate receptor-deficient mouse cortical neuronal cells.
Eur. J. Neurosci.
8:
69-78,
1996[Medline].
39.
Torres, G. E.,
T. M. Egan,
and
M. M. Voigt.
Hetero-oligomeric assembly of P2x receptor subunits.
J. Biol. Chem.
274:
6653-6659,
1999
40.
Virginio, C.,
A. MacKenzie,
F. A. Rassendren,
R. A. North,
and
A. Surprenant.
Pore dilation of neuronal P2x receptor channels.
Nat. New Biol.
2:
315-321,
1999.
41.
Waldmann, R.,
G. Champigny,
N. Voilley,
I. Lauritzen,
and
M. Lazdunski.
The mammalian degenerin MDEG, an amiloride-sensitive cation channel activated by mutations causing neurodegeneration in Caenorhabditis elegans.
J. Biol. Chem.
271:
10433-10436,
1996
42.
Warny, M.,
and
C. P. Kelly.
Monocyte cell necrosis is mediated by potassium depletion and caspase-like proteases.
Am. J. Physiol.
276 (Cell Physiol. 45):
C717-C724,
1999
43.
Wiley, J. S.,
C. E. Gargett,
W. Zhang,
M. B. Snook,
and
G. P. Jamieson.
Partial agonists and antagonists reveal a second permeability state of human lymphocyte P2Z/P2X7 channel.
Am. J. Physiol.
275 (Cell Physiol. 44):
C1224-C1231,
1998
44.
Zheng, L. M.,
A. Zychlinsky,
C.-C. Liu,
D. M. Ojcius,
and
J. D. E. Young.
Extracellular ATP as a trigger for apoptosis or programmed cell death.
J. Cell Biol.
112:
279-288,
1991
This article has been cited by other articles:
![]() |
W. P. Schilling, D. Snyder, W. G. Sinkins, and M. Estacion Palytoxin-induced cell death cascade in bovine aortic endothelial cells Am J Physiol Cell Physiol, October 1, 2006; 291(4): C657 - C667. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-H. Jiang, F. Rassendren, A. Mackenzie, Y.-H. Zhang, A. Surprenant, and R. A. North N-methyl-D-glucamine and propidium dyes utilize different permeation pathways at rat P2X7 receptors Am J Physiol Cell Physiol, November 1, 2005; 289(5): C1295 - C1302. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Liang and E. M. Schwiebert Large pore formation uniquely associated with P2X7 purinergic receptor channels. Focus on "Are second messengers crucial for opening the pore associated with P2X7 receptor?" Am J Physiol Cell Physiol, February 1, 2005; 288(2): C240 - C242. [Full Text] [PDF] |
||||
![]() |
R. X. Faria, F. P. DeFarias, and L. A. Alves Are second messengers crucial for opening the pore associated with P2X7 receptor? Am J Physiol Cell Physiol, February 1, 2005; 288(2): C260 - C271. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Y. Kochukov and A. K. Ritchie A P2X7 receptor stimulates plasma membrane trafficking in the FRTL rat thyrocyte cell line Am J Physiol Cell Physiol, October 1, 2004; 287(4): C992 - C1002. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Wisnoskey, M. Estacion, and W. P. Schilling Maitotoxin-induced cell death cascade in bovine aortic endothelial cells: divalent cation specificity and selectivity Am J Physiol Cell Physiol, August 1, 2004; 287(2): C345 - C356. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Estacion, J. S. Weinberg, W. G. Sinkins, and W. P. Schilling Blockade of maitotoxin-induced endothelial cell lysis by glycine and L-alanine Am J Physiol Cell Physiol, April 1, 2003; 284(4): C1006 - C1020. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. North Molecular Physiology of P2X Receptors Physiol Rev, October 1, 2002; 82(4): 1013 - 1067. [Abstract] [Full Text] |